The Foundation of Sarcoidosis Research (FSR) maintains a strong Scientific Advisory Board (SAB) composed of world renowned key opinion leaders within the fields of sarcoidosis, medical research, therapy development, and medical practice. The SAB helps advance FSR towards its mission dedicated to finding a cure for this disease and to improving care for sarcoidosis patients.
Current Members:
Current Members:
Elliott Crouser, MD
SAB Chair
Ohio State University
Robert Baughman, MD
John Belperio, MD
UCLA Medical Center
Edward Chen, MD
Johns Hopkins University
Ennis James, MD
Medical University of South Carolina
Craig Lipset
Managing Partner
Clinical Innovation Partners
Lisa Maier, MD, MSPH, FCCP
National Jewish Health
Adam Morgenthau, MD
Icahn School of Medicine at Mount Sinai
Misha Rosenbach, MD
University of Pennsylvania
Milton Rossman, MD
University of Pennsylvania
Barney Stern, MD
University of Maryland
Members starting in 2025:
Nicholas Arger, MD
University of California San Francisco
Matthew Baker, MD, MS
Stanford University
Maneesh Bhargava, MBBS, PhD
University of Minnesota
David Birnie, MB, MRCP, MD
University of Ottawa
Avrom Caplan, MD
New York University
Jeffrey Gelfand, MD
University of California San Francisco
Mridu Gulati, MD, MPH
Yale University
Sotonye Imadojemu, MD, MPH
Brigham and Women’s Hospital
Jordana Kron, MD
Virginia Commonwealth University
Courtney Montgomery, PhD
Oklahoma Medical Research Foundation
Natalia Rivera, PhD, MS
Karolinska Institute
Lobelia Samavati, MD
Wayne State University
Peter Sporn, MD
Northwestern University
Arthur Yee, MD, PhD
Cornell University and the Hospital for Special Surgery
Please note: While FSR receives guidance and input from our Scientific Advisory Board (SAB), it is not to be implied that all SAB members support or are in agreement in each specific FSR initiative or approach. As with most professional groups, members may have differing perspectives and opinions on various issues. FSR’s intent is always to work toward consensus with our experts as much as feasible while addressing patient and research needs.